Stage IV lung cancer survivor: Targeted therapy and surgery left me cancer-free

-



immuno therapy for lung cancer :: Article Creator

Roche Immunotherapy Fails In Lung Cancer Study, Raising Questions About Drug's Target

LONDON — An experimental cancer treatment from Roche failed to improve survival in a major lung cancer study, the company said Tuesday, a result that will further stoke doubts about the drug's target.

In a short statement, Roche said that a combination of the drug, called tiragolumab, with its existing medicine Tecentriq did not outperform Tecentriq alone on the study's primary endpoint of overall survival. The Phase 3 study, known as SKYSCRAPER-01, included more than 500 patients with a form of advanced non-small cell lung cancer. 

Tiragolumab was designed to target a protein called TIGIT, which in recent years was seen as the next blockbuster opportunity in cancer immunotherapy. Roche and other biopharma companies poured resources into standing up anti-TIGIT programs, thinking they could augment the results of the very successful drugs that go after another protein, PD-1. 

STAT+ Exclusive Story

STAT+ Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Individual plans Group plans View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Diabetes Drug Metformin Might Help Fight Lung Cancer

Just a moment...

This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

Press and Hold

Press and hold the button

If you believe this is an error, please contact our support team.

167.71.87.121 : cba2d585-c227-4539-882c-11684a78


Colorado Man's Lung Cancer Care With Immunotherapy

Your browser is not supportedusatoday.Com

logo

usatoday.Com wants to ensure the best experience for all of our readers, so we built our site to take advantage of the latest technology, making it faster and easier to use.

Unfortunately, your browser is not supported. Please download one of these browsers for the best experience on usatoday.Com





Comments

Post a Comment

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

-
Image
stage 3 lung cancer spread to brain :: Article Creator Tracking Lung Cancer's Path It's common for lung cancer to metastasize, or spread. In fact, 57 percent of lung cancer patients are diagnosed when the cancer has already metastasized, according to an editorial in the Annals of Cancer Epidemiology. [1] Lung cancer also has a preferred path, traveling most often to the bones, brain, adrenal glands, and liver. [2] [3] Why Does Lung Cancer Spread So Easily? Lung cancer may metastasize readily because the lungs are a cellular traffic hub of the body. "The job of the airway is to deliver oxygen to all of your cells, so it's easy for cancer cells to get from the airway lining to the blood and spread to other organs," says Paul Bunn, MD, a professor of medical oncology at the University of Colorado School of Medicine in Aurora. Why Do Lung Cancer Cells Spread to Certain Organs? "Some organs produce a cellular si...
Read more

Free biotech stocks directory, pharma stocks, telemedicine stocks ...

-
Image
stage 4 cervical cancer :: Article Creator Uterine Cancer Stages If you get a diagnosis of uterine cancer, your doctor may tell you what stage it is. It's a way to figure out how advanced your cancer is and what kind of treatment works best. Before your doctor decides your stage, they'll use tests, such as a biopsy and ultrasound, to find what type of uterine cancer you have. Also called the womb, the uterus is a pear-shaped organ where babies grow. There are two kinds of uterine cancer. Endometrial cancer, the most common form, begins in the inner lining of the uterus. Uterine sarcoma is a rare type that starts in the muscles in the uterus or the surrounding tissue. Doctors use two ways to decide the stage of uterine cancer. One is a method created by the International Federation of Gynecology and Obstetrics (FIGO). The other is the American Joint Committee of Cancer TNM staging system. The two methods are almost the same. Both sy...
Read more

Respirology | APSR Respiratory Medicine Journal

-
Image
stage 3 pancreatic cancer :: Article Creator Know The Symptoms: Pancreatic Cancer This year, approximately 1,000 Alabama residents will be diagnosed with pancreatic cancer. With a trending increase in cases for patients under the age of 55, experts at the University of Alabama at Birmingham Department of Surgery say it is important for individuals to familiarize themselves with common signs and symptoms associated with pancreatic cancer to reduce their risk and identify key indicators of the disease. "Pancreatic cancer is known for its reputation of being harder to detect in its earliest stages," said J. Bart Rose, M.D., an associate professor in the UAB Division of Surgical Oncology. "Fortunately, there are still several ways you can reduce your chances of pancreatic-related illness and monitor your overall well-being for any sudden changes." Lifestyle changesThe pancreas is a vital organ to both the endocrine and digestive ...
Read more